Arthur A. Levin, Director: Avidity Biosciences RNA Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $53,539.2
Shares · price: 1,872 sh · $28.60 a share
Held after: 12,958 sh
Stock: Avidity Biosciences RNA
Person: Arthur A. LevinDirector
Trade date: 25/01/21
Filed: 25/01/23
Days to filing: 2 days

Sold 12.6% of holdings

Share of holding sold: 12.6%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 24/12/22~25/02/20

Arthur A. Levin's recent trades

Arthur A. LevinDirector
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$22.3K
605 sh
$22.3K
Filed 03/17
Traded 03/13
Arthur A. LevinDirector
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$22.1K
605 sh
$22.1K
Filed 03/13
Traded 03/13
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$127.4K
1,758 sh
$127.4K
Filed 01/23
Traded 01/21
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$5.1M
107,500 sh
$5.1M
Filed 25/08/08
Traded 25/08/06
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$140K
3,323 sh
$140K
Filed 24/11/20
Traded 24/11/19